Neurocrine Biosciences NBIX Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's total cost of revenue?
- Neurocrine Biosciences (NBIX) reported total cost of revenue of $13.8M in Q1 2026.
- How has Neurocrine Biosciences's total cost of revenue changed year-over-year?
- Neurocrine Biosciences's total cost of revenue increased by 50.0% year-over-year, from $9.2M to $13.8M.
- What is the long-term trend for Neurocrine Biosciences's total cost of revenue?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's total cost of revenue has grown at a 38.2% compound annual growth rate (CAGR), from $14.3M to $52.1M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.